Now the risk of death from cervical cancer will reduce by 40 percent

Cervical Cancer New Treatment : The risk of cervical cancer is increasing rapidly not only in India but all over the world. According to WHO, it is the fourth most common cancer in women, with about 6.6 lakh new cases occurring every year. Of these, 3.5 lakh deaths occur. There are about 3,200 cases of cervical cancer and 800 deaths every year in the UK.

Most of these affected women are around the age of 30. In such a situation, an effective treatment for this cancer has been found. After 10 years of testing, medical science has made a big achievement. The new method of treatment will reduce the risk of death from cervical cancer by about 40%.

Also read: Health Tips: If you use the phone for a long time while sitting in the toilet, these serious diseases can occur.

what is cervical cancer

Cervical cancer is caused by human papilloma virus (HPV). There is a risk of infection with this virus if you have sex with more than one partner. One should be alert if there is bleeding from the vagina, excessive liquid discharge, foul smell and pain while having physical relations. When such symptoms are seen, testing is done by Pap smear, cervical biopsy, abdominal ultrasound.

What is the new treatment for cervical cancer?

A new treatment is said to be very effective in the treatment of cervical cancer. This reduces the risk of death of patients by 40%, which is considered to be the best treatment against this disease in the last 25 years. In this new treatment, patients are given a short course of chemotherapy, after which they are given a combination of chemotherapy and radiotherapy. This treatment has been successful in 10-year long testing in UK, Mexico, India, Italy and Brazil.

Also read: From excessive fatigue to weight loss, these are the five major symptoms of cancer.

What do researchers say?

Researchers at University College London found that this new treatment not only reduces the risk of death for patients, but also reduces the risk of cancer returning by 35%. The results of the research have been published in Lancet magazine. Dr. Mary McCormack, head of this testing, said, ‘This is the best treatment so far in the treatment of cervical cancer.’ Now there is a demand to bring it worldwide. Dr. Ian Fowles, Executive Director of Cancer Research UK, said, ‘This treatment is a new ray of hope for cervical cancer patients.’